SPRY R&D Expenses
Ars Pharmaceuticals Inc · R&D Expenses
SPRY R&D Expenses
Latest reported$15.23Mperiod ending
SPRY TTM R&D Expenses ($24.18M → $15.23M)
TTM R&D Expenses
High-resolution chart · PNG
SPRY r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 15,228,000 | |
| 14,565,000 | |
| 13,181,000 | |
| 12,765,000 | |
| 14,437,000 | |
| 17,298,000 | |
| 19,580,000 | |
| 19,957,000 | |
| 18,536,000 | |
| 18,948,000 | |
| 20,266,000 | |
| 21,572,000 | |
| 22,463,000 | |
| 19,505,000 | |
| 18,376,000 | |
| 17,580,000 | |
| 18,809,000 | |
| 20,077,500 | |
| 20,273,000 | |
| 25,007,000 | |
| 24,873,000 | |
| 23,529,500 | |
| 24,184,000 |